Coya Therapeutics's top three insider shareholders as of July 26, 2026 are Dov A Md Goldstein (Director, 27.56K shares), Arun Swaminathan (Chief Executive Officer, 10.00K shares), Adrian Hepner (Chief Medical Officer, 10.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Dov A Md Goldstein | - | 27,557 | 0 | 19 Aug, 2025 |
| David S Snyder | Chief Financial Officer | 8,800 | 0 | 14 Nov, 2024 |
| Adrian Hepner | Chief Medical Officer | 10,000 | 0 | 04 Jan, 2023 |
| Hideki Garren | - | 2,000 | 0 | 04 Jan, 2023 |
| Anabella Villalobos | - | 10,000 | 0 | 04 Jan, 2023 |
| Howard Berman | Chief Executive Officer | 10,000 | 0 | 04 Jan, 2023 |
| Fred Grossman | Chief Medical Officer | 2,710 | 0 | 12 Nov, 2024 |
| Arun Swaminathan | Chief Executive Officer | 10,000 | 0 | 13 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Mark H Pavao | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 22 Jan, 2026 | Arun Swaminathan | Stock Option (right to buy) | A | 293,983 | $0.00 | 293,983 | D | A |
| 22 Jan, 2026 | Arun Swaminathan | Stock Option (right to buy) | A | 293,983 | $0.00 | 293,983 | D | A |
| 22 Jan, 2026 | Arun Swaminathan | Stock Option (right to buy) | A | 293,983 | $0.00 | 293,983 | D | A |
| 22 Jan, 2026 | Fred Grossman | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | David S Snyder | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | David S Snyder | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Howard Berman | Stock Option (right to buy) | A | 15,257 | $0.00 | 15,257 | D | A |
| 22 Jan, 2026 | David S Snyder | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Fred Grossman | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | David S Snyder | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Fred Grossman | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Arun Swaminathan | Stock Option (right to buy) | A | 293,983 | $0.00 | 293,983 | D | A |
| 22 Jan, 2026 | Fred Grossman | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 02 Jan, 2026 | Anabella Villalobos | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Ann Lee | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Ann Lee | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Anabella Villalobos | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Anabella Villalobos | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Ann Lee | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |